TheraRadar

JW

Pre-Approval PRO BETA
66
Total Trials
16
Phase 3
7
Phase 2
7
Recruiting
402
Score

Pipeline by Phase

Phase 3
16
Phase 2
7
Phase 1
27

Therapeutic Focus

Healthy Type 2 Diabetes Mellitus Hypertension Gout Dyslipidemia

Clinical Trials (66)

NCT07378098 Phase 3 RECRUITING

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Started: 2/3/2026

NCT06643130 Phase 3 RECRUITING

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Started: 12/2/2024

NCT05815901 Phase 3 ACTIVE NOT RECRUITING

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Started: 3/21/2023

NCT05814393 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus

Started: 1/3/2023

NCT05814406 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

Started: 1/12/2023

NCT06955104 Phase 3 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

Started: 4/3/2025

NCT05331014 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

Started: 11/15/2021

NCT04584736 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Started: 6/11/2019

NCT04027517 Phase 3 COMPLETED

A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

Started: 1/15/2019

NCT01705197 Phase 3 COMPLETED

This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.

Started: 2/1/2012

NCT01529541 Phase 3 COMPLETED

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

Started: 5/1/2011

NCT01402843 Phase 3 COMPLETED

Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia

Started: 6/1/2011

NCT01256736 Phase 3 COMPLETED

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Started: 3/1/2010

NCT01529528 Phase 3 COMPLETED

A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients

Started: 5/1/2011

NCT01211834 Phase 3 COMPLETED

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Started: 10/1/2009

NCT00903981 Phase 3 COMPLETED

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

Started: 3/1/2009

NCT05117060 Phase 2 COMPLETED

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

Started: 12/13/2021

NCT04853992 Phase 2 COMPLETED

Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

Started: 5/10/2021

NCT04804111 Phase 2 COMPLETED

Study of of URC102 to Assess the Efficacy and Safety in Gout Patients

Started: 1/21/2019

NCT02290210 Phase 2 COMPLETED

Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients

Started: 7/24/2014

NCT02557126 Phase 2 COMPLETED

Study of URC102 to Assess the Safety and Efficacy in Gout Patients

Started: 10/1/2015

NCT00888719 Phase 2 COMPLETED

Therapeutic Exploratory Study of CWP-0403

Started: 2/1/2009

NCT07514780 Phase 1 RECRUITING

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

Started: 4/13/2026

NCT06703710 Phase 1 RECRUITING

To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

Started: 1/6/2025

NCT06435442 Phase 1 COMPLETED

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

Started: 6/3/2024

NCT07374406 Phase 1 COMPLETED

To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Started: 2/2/2026

NCT03055286 Phase 1 TERMINATED

Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Started: 2/6/2017

NCT06754943 Phase 1 COMPLETED

To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105

Started: 1/17/2025

NCT01764178 Phase 1 COMPLETED

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

Started: 1/22/2013

NCT06665425 Phase 1 COMPLETED

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

Started: 3/24/2025

NCT07036458 Phase 1 COMPLETED

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Started: 8/22/2025

NCT06816719 Phase 1 COMPLETED

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107

Started: 9/2/2024

NCT04203836 Phase 1 COMPLETED

A Trial to Evaluate the Effect of Food on LEO 152020

Started: 1/9/2020

NCT05508776 Phase 1 COMPLETED

A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People

Started: 9/16/2022

NCT06378684 Phase 1 COMPLETED

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

Started: 9/10/2023

NCT06361277 Phase 1 COMPLETED

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

Started: 11/3/2023

NCT06355349 Phase 1 COMPLETED

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

Started: 4/28/2023

NCT05433844 Phase 1 COMPLETED

To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers

Started: 6/2/2022

NCT05784155 Phase 1 COMPLETED

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

Started: 3/10/2023

NCT05198778 Phase 1 COMPLETED

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

Started: 11/29/2021

NCT05351840 Phase 1 COMPLETED

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

Started: 11/2/2020

NCT05463497 Phase 1 COMPLETED

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

Started: 1/17/2022

NCT02524678 Phase 1 COMPLETED

Phase 1 Study(Additional) of URC102 in Healthy Subjects

Started: 8/5/2015

NCT04018170 Phase 1 COMPLETED

Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

Started: 2/15/2019

NCT02426723 Phase 1 COMPLETED

Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients

Started: 10/19/2015

NCT01953497 Phase 1 COMPLETED

Phase 1 Study of URC102 in Healthy Subjects

Started: 5/23/2013

NCT01398462 Phase 1 COMPLETED

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Started: 7/1/2011

NCT01406431 Phase 1 COMPLETED

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

Started: 8/1/2011

NCT01443221 Phase 1 COMPLETED

Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

Started: 12/1/2010

NCT07442006 Phase 4 RECRUITING

Glycemic Variability of Combination Therapies in T2DM

Started: 10/29/2025

NCT07442630 Phase 4 ACTIVE NOT RECRUITING

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

Started: 8/21/2023

NCT01166633 Phase 4 COMPLETED

Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

Started: 6/1/2009

NCT04810507 Phase 4 COMPLETED

MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus

Started: 11/9/2018

NCT00889226 Phase 4 COMPLETED

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

Started: 4/1/2008

NCT02056847 Phase 4 COMPLETED

to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

Started: 9/1/2013

NCT02106182 Phase 4 COMPLETED

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

Started: 1/2/2014

NCT00701285 Phase 4 COMPLETED

South Korean Pitavastatin Heart Failure Study

Started: 7/1/2008

NCT01111630 Phase 4 COMPLETED

Study of Erythropoietin (EPO) Administration Schedule

Started: 10/1/2009

NCT01533389 Phase 4 COMPLETED

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

Started: 10/1/2011

NCT01228370 Phase 4 COMPLETED

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Started: 4/1/2011

NCT00786734 Phase 4 WITHDRAWN

Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)

Started: 8/1/2008

NCT00663884 Phase 4 COMPLETED

Glufast On Insulin Glargine Trial in Type 2 DM

Started: 2/1/2008

NCT00802139 Phase 4 COMPLETED

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

Started: 2/1/2008

NCT01259531 Phase 4 COMPLETED

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)

Started: 12/1/2010

NCT00640276 Phase 4 COMPLETED

Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

Started: 4/1/2008

NCT01260129 Phase 4 COMPLETED

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH

Started: 10/1/2010

Drug Candidates

Epaminurad, Naproxen Epaminurad Epaminurad placebo Epaminurad 6 mg Epaminurad 9 mg Febuxostat 40 mg Febuxostat 80 mg Epaminurad 6 mg placebo Epaminurad 9 mg placebo Febuxostat 40 mg placebo
Activity Status: Active
Last Trial Started: 4/13/2026
Last Trial Ended: 2/24/2026
Trials (12 months): 5
Completed Trials: 57
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.